Male infertility with normal virilization due to meiosis defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:217034
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Male infertility with normal virilization due to meiosis defect (Orphanet code 217034) is a rare genetic condition in which affected males present with infertility despite having normal masculine physical development (virilization). This means that secondary sexual characteristics such as body hair, muscle mass, voice deepening, and external genital development are entirely normal, and testosterone levels are typically within the normal range. The underlying problem lies in a defect in meiosis — the specialized cell division process required to produce sperm cells (spermatozoa). Because meiosis is disrupted, sperm production is severely impaired, leading to azoospermia (absence of sperm in the ejaculate) or severe oligozoospermia (very low sperm count), which results in infertility. The reproductive system is the primary body system affected. Testicular biopsy in affected individuals typically reveals maturation arrest at various stages of meiosis, meaning that germ cells fail to complete the divisions necessary to form mature spermatozoa. The condition is distinguished from other causes of male infertility by the combination of normal androgen function (normal virilization and hormonal profile) with isolated spermatogenic failure due to a specific meiotic defect. Several genes involved in meiotic processes have been implicated in different families. Currently, there is no curative treatment that can restore normal meiosis in affected individuals. Management focuses on reproductive counseling and assisted reproductive technologies. In some cases where residual spermatogenesis exists, testicular sperm extraction (TESE) combined with intracytoplasmic sperm injection (ICSI) may offer a chance of biological parenthood, though success depends on the severity of the meiotic arrest. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Male infertility with normal virilization due to meiosis defect.

View clinical trials →

No actively recruiting trials found for Male infertility with normal virilization due to meiosis defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Male infertility with normal virilization due to meiosis defect community →

No specialists are currently listed for Male infertility with normal virilization due to meiosis defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Male infertility with normal virilization due to meiosis defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Male infertility with normal virilization due to meiosis defectForum →

No community posts yet. Be the first to share your experience with Male infertility with normal virilization due to meiosis defect.

Start the conversation →

Latest news about Male infertility with normal virilization due to meiosis defect

1 articles
Clinical trialCLINICALTRIALSApr 15, 2026
Trial Now Recruiting: IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Specimens (NCT07074015)
Researchers are testing a new AI-powered tool called IntelliWell that can find sperm cells in testicular tissue samples that appeared to have no sperm when chec
See all news about Male infertility with normal virilization due to meiosis defect

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Male infertility with normal virilization due to meiosis defect

What is Male infertility with normal virilization due to meiosis defect?

Male infertility with normal virilization due to meiosis defect (Orphanet code 217034) is a rare genetic condition in which affected males present with infertility despite having normal masculine physical development (virilization). This means that secondary sexual characteristics such as body hair, muscle mass, voice deepening, and external genital development are entirely normal, and testosterone levels are typically within the normal range. The underlying problem lies in a defect in meiosis — the specialized cell division process required to produce sperm cells (spermatozoa). Because meiosi

At what age does Male infertility with normal virilization due to meiosis defect typically begin?

Typical onset of Male infertility with normal virilization due to meiosis defect is adult. Age of onset can vary across affected individuals.